News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy
Armando Orlandi/photos.asco.org
Mar 6, 2025, 10:57

Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Maurizio Callari, et al. on X:

“Cowabunga!

Riding Breast Cancer‘s Biggest Data’s Wave from Literature.

NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemo!

High TIL + low ER signaling = 72.7% pCR. TP53 mutations spell trouble though!

Targeting PAK4 for RD?”

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Authors: Maurizio Callari, et al.

Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy

Agostino Gemelli University Policlinic Armando Orlandi Breast Cancer cancer chemotherapy fight against cancer Global fight against cancer Maurizio Callari OncoDaily Oncology
Special Coverage
Blog
May 1, 2025, 18:12
Alastair Lamb highlights BJUI session on AI and Medicolegal topics at AUA25
Blog
May 1, 2025, 18:05
Misty Dawn Shields: An amazing night at the "Evening of Promise" gala hosted by American Lung Association
Blog
May 1, 2025, 18:04
Karuna Ganesh reveals E. coli’s role in early-onset colorectal cancer Initiation at AACR25
Drugs
May 1, 2025, 17:54
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Insight
May 1, 2025, 17:49
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Opinion
May 1, 2025, 17:39
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Insight
May 1, 2025, 17:30
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Blog
May 1, 2025, 17:29
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Blog
May 1, 2025, 17:15
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Drugs
May 1, 2025, 17:14
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25
Blog
May 1, 2025, 17:09
Aynur Aktas: Our Abstract Has Been Selected for Oral Presentation at MASCC 2025
Insight
May 1, 2025, 17:01
Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma - ECOG-ACRIN Cancer Research Group